12:20 PM
Jul 31, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Schizophrenia; depression

Cell culture studies suggest inhibiting DISC1-FBXW7 binding could help treat schizophrenia and major depressive disorder (MDD). In human neuroprogenitor cells (NPCs) differentiated from induced pluripotent stem...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >